Morgan Stanley Clearside Biomedical, Inc. Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Morgan Stanley holds 131,998 shares of CLSD stock, worth $116,158. This represents 0.0% of its overall portfolio holdings.

Number of Shares

131,998

Previous 130,196 1.38%

Holding current value

$116,158

Previous $165,000 20.61%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.87 - $1.58 $1,567 - $2,847	1,802 Added 1.38%	131,998 $131,000
Q3 2024 Nov 14, 2024	SELL	$0.93 - $1.35 $14,688 - $21,321	-15,794 Reduced 10.82%	130,196 $165,000
Q2 2024 Oct 17, 2024	SELL	$1.08 - $1.58 $7,618 - $11,145	-7,054 Reduced 4.61%	145,990 $189,000
Q2 2024 Aug 14, 2024	SELL	$1.08 - $1.58 $7,618 - $11,145	-7,054 Reduced 4.61%	145,990 $189,000
Q1 2024 Oct 17, 2024	BUY	$1.2 - $2.02 $8,464 - $14,249	7,054 Added 4.83%	153,044 $234,000
Q1 2024 Aug 16, 2024	BUY	$1.2 - $2.02 $10,332 - $17,392	8,610 Added 5.96%	153,044 $234,000
Q1 2024 May 15, 2024	BUY	$1.2 - $2.02 $10,332 - $17,392	8,610 Added 5.96%	153,044 $234,000
Q4 2023 Aug 16, 2024	SELL	$0.68 - $1.18 $1,058 - $1,836	-1,556 Reduced 1.07%	144,434 $168,000
Q4 2023 Feb 13, 2024	SELL	$0.68 - $1.18 $15,869 - $27,538	-23,338 Reduced 13.91%	144,434 $168,000
Q3 2023 Nov 15, 2023	SELL	$0.82 - $1.27 $4,122 - $6,385	-5,028 Reduced 2.91%	167,772 $145,000
Q2 2023 Aug 14, 2023	BUY	$0.97 - $1.48 $117,522 - $179,312	121,157 Added 234.6%	172,800 $193,000
Q1 2023 May 15, 2023	BUY	$0.93 - $1.66 $8,367 - $14,935	8,997 Added 21.1%	51,643 $53,000
Q4 2022 Feb 14, 2023	SELL	$1.0 - $1.5 $75,031 - $112,546	-75,031 Reduced 63.76%	42,646 $47,000
Q3 2022 Nov 14, 2022	SELL	$1.08 - $1.83 $522,779 - $885,820	-484,055 Reduced 80.44%	117,677 $133,000
Q2 2022 Oct 27, 2022	SELL	$1.3 - $2.49 $702,140 - $1.34 Million	-540,108 Reduced 47.3%	601,732 $885,000
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.49 $702,140 - $1.34 Million	-540,108 Reduced 47.3%	601,732 $885,000
Q1 2022 Oct 27, 2022	BUY	$1.35 - $2.88 $729,145 - $1.56 Million	540,108 Added 89.76%	1,141,840 $2.62 Million
Q1 2022 May 13, 2022	SELL	$1.35 - $2.88 $627,162 - $1.34 Million	-464,565 Reduced 28.92%	1,141,840 $2.62 Million
Q4 2021 Feb 14, 2022	BUY	$2.72 - $5.72 $2.18 Million - $4.58 Million	799,850 Added 99.17%	1,606,405 $4.42 Million
Q3 2021 Nov 15, 2021	BUY	$4.83 - $7.2 $3.9 Million - $5.81 Million	806,555 New	806,555 $4.84 Million

Others Institutions Holding CLSD

# of Institutions

Shares Held

11.6M

Call Options Held

24K

Put Options Held

12.1K

View Full List

About Clearside Biomedical, Inc.

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $53M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

More about CLSD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account